Yatırımcı.AI

BISTTRY18:19Live

Orzaks İlaç ve Kimya Sanayi Ticaret A.Ş.

ORZAX Ratio Analysis: P/E, P/B, EV/EBITDAOrzaks İlaç ve Kimya Sanayi Ticaret A.Ş.

Main MarketChemicals, Petroleum, Rubber and Plastics
68.10−2.50 (−3.54%)
Volume
TRY 296.5M
Day range
66.80 – 72.90
Previous close
70.60
Market cap
TRY 23.1B

Last updated: Source: Borsa Istanbul, 15-minute delayed

35 key ratios for Orzaks İlaç ve Kimya Sanayi Ticaret A.Ş. (ORZAX) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E16.03
P/B3.52
EV/EBITDA60.40
Dividend yield—
Beta—
Earnings per share4.3 TL
Book value per share19.3 TL
EBITDA2.4B TL
Net profit1.1B TL
Operating profit2.2B TL
Operating profit before finance costs2.4B TL
Net working capital3.8B TL
Gross margin65.52%
Operating margin28.98%
Net margin13.80%
Return on assets12.90%
Return on equity26.35%
Current ratio1.81
Quick ratio1.45
Cash ratio—
Leverage ratio46.75
Debt to equity0.88
Debt to assets0.47
Fixed assets to equity0.58
Short-term debt share0.55
Interest coverage—
Receivables turnover1.35
Days sales outstanding270
Inventory turnover1.54
Days inventory outstanding237
Payables turnover3.67
Days payables outstanding99
Working capital turnover2.00
Equity turnover1.16
Asset turnover0.62

Frequently Asked Questions

ORZAX has a P/E ratio of 16.03, a P/B ratio of 3.52 and an EV/EBITDA of 60.40.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.